Full List Of Stories
Motif Bio submits meeting request to FDA over iclaprim situation
Clinical-stage biopharmaceutical company Motif Bio has submitted a meeting request and package to the US Food & Drug Administration (FDA) related to its lead product candidate ‘iclaprim’, it said on Monday.
Portmeirion buying US homewares firm Nambe in $12m deal
Homewares manufacturer and distributor Portmeirion Group announced the acquisition of US based premium homewares business Nambé on Monday, for a cash consideration of $12m.
Geographic diversity providing stability for Hydrogen Group
Specialist recruitment company Hydrogen Group updated the market on its trading for the six months ended 30 June on Monday, reporting that it had continued to trade in line with its expectations.
Spectra Systems signs on European lottery customer, renews with US operator
Banknote authentication and brand protection specialist Spectra Systems Corporation has been selected by an unnamed “major” European lottery to provide its ‘Premier64 Integrity’ internal control system (ICS), it announced on Monday.
Asia report: Markets mixed as China GDP growth slows further
Markets in Asia finished in a mixed state on Monday, as investors reacted to fresh GDP data from China which suggested a seriously slow rate of growth for the world’s second-largest economy.
Egdon Resources issues positive update from Biscathorpe-2
Egdon Resources issued what it called a “positive update” on Monday on the Biscathorpe-2 exploration well drilled at Petroleum Exploration and Development Licence PEDL253, located in Lincolnshire, where it held a 35. 8% interest.
Alpha Growth achieves 'several milestones' in second quarter
Financial services specialist Alpha Growth released a quarterly update on Monday, reporting that through the second quarter it achieved “several” milestones, and continued to advance its other strategies.
Location Sciences ropes in Andy Roberts to strengthen advisory panel
Location data verification and analytics provider Location Sciences announced the appointment of Andy Roberts to strengthen its advisory panel on Monday.
Providence agrees another extension as APEC submits Barryroe payment
Ireland-based energy company Providence Resources released a commercial and operational update in relation to Standard Exploration Licence 1/11 on Monday, which contains the Barryroe oil accumulation.
Tertiary Minerals reports two target zones for zinc-silver at Paymaster
Tertiary Minerals advised on Monday that initial follow-up field reconnaissance of soil anomalies at its recently-acquired Paymaster Polymetallic Project in Nevada had identified two zones of zinc-silver mineralisation for follow-up exploration and drilling.
Pershing Square announces $400m private bond placement
Pershing Square Holdings announced a fully-committed private placement of $400m of bonds on Monday, with a coupon of 4. 95%, maturing on 15 July 2039.
IP Group upbeat on news from portfolio firms Ceres Power and Istesso
IP Group confirmed on Monday that its portfolio company Ceres Power Holdings has signed a collaboration and licensing agreement with Doosan Corporation to jointly develop SOFC distributed power systems, initially targeted at the Korean commercial building market.
AstraZeneca gets complete response from FDA over 'Farxiga'
AstraZeneca announced on Monday that the US Food and Drug Administration (FDA) has issued a complete response letter regarding the supplemental New Drug Application for ‘Farxiga’ (dapagliflozin) as an adjunct treatment to insulin to improve glycaemic control in adult patients with type-1 diabetes, when insulin alone does not provide adequate glycaemic control.
GlaxoSmithKline reveals positive results from 'Zejula' ovarian cancer trial
GlaxoSmithKline announced positive results from its ‘PRIMA’ phase 3 randomised, double-blind, placebo-controlled study of ‘Zejula’ (niraparib) as a maintenance therapy in patients with first-line ovarian cancer following platinum-based chemotherapy on Monday.
Sports Direct delays publication of preliminary results, Bank of Georgia gets loan for local currency funding
London open The FTSE 100 is expected to open two points higher on Monday, having closed down 0. 05% at 7,505. 97 on Friday.